NATIONAL TUBERCULOSIS INDICATORS · CDC publishes TB indicator data to assist in evaluating...

CS280337

NATIONAL TUBERCULOSIS INDICATORS2015 STATE COMPARISON

The Centers for Disease Control and Prevention (CDC) collects information from state and local health departments about each newly reported case of tuberculosis (TB) in the United States (U.S.). Reporting areas (i.e., the 50 states, the District of Columbia, several large U.S. cities, Puerto Rico, and other U.S.-affiliated jurisdictions in the Pacific and Caribbean) submit their information about TB cases to CDC’s National TB Surveillance System (NTSS) with a standard form, the Report of Verified Case of Tuberculosis (RVCT). The initial case report includes a patient’s demographic data, occupation, initial drug regimen, and information on HIV status, substance abuse, homelessness, and residence in correctional or long term-care facilities. Follow-up reports collect drug susceptibility test results for Mycobacterium tuberculosis isolates and treatment status, among other items.

CDC also collects information from reporting areas about their contact investigation activities: finding and examining persons who have had contact with TB cases, and treating those found to have TB disease or latent TB infection (LTBI). Data for contact investigation are reported by each TB control jurisdiction annually through the Aggregate Reports for Program Evaluation (ARPE).

National TB Indicators are key process and outcome measures for TB control programs in the United States. These indicators are selected by CDC in cooperation with partners in state and local health departments. Data for calculating these indicators are derived from existing surveillance systems such as NTSS and ARPE. CDC publishes TB indicator data to assist in evaluating progress toward achievement of national objectives through monitoring of TB program performance, assessment of needs for education and technical assistance, and identification of areas that need improvement.1,2

Incidence3

Elimination of TB is defined as reducing TB disease incidence in the United States to less than 1 case per million persons per year. Therefore, measuring the number of new cases occurring each year remains the best overall indicator of progress toward TB elimination. In 2015, TB incidence in the United States was 3.0 overall TB cases (including U.S.-born and foreign-born persons) per 100,000 persons (30 per million). Overall, TB incidence has begun to level off over the past few years and the nation has not yet achieved the 2020 national target of ≤1.4 cases per 100,000 (Figures 1 and 2).

1Data in this report are based on the final 2015 dataset from the National TB Surveillance System (NTSS).

2For more information about the National TB Program Objectives and Performance Targets for 2020 please visit http://www.cdc.gov/tb/programs/ evaluation/indicators/default.htm.

3Salinas J, Mindra G, Haddad M, Pratt R, Price S, Langer A. Leveling of Tuberculosis Incidence—United States, 2013–2015. MMWR Morb Mortal Wkly Rep. 2016;65(11):273–8.

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination

http://www.cdc.gov/tb/programs/evaluation/indicators/default.htm

http://www.cdc.gov/tb/programs/evaluation/indicators/default.htm

NATIONAL TB INDICATORS | 2015 STATE COMPARISON

of 12

Figures 1 and 2. Overall TB Incidence*, United States, 2015

D.C.

Met 2020 target (≤1.4)*Above 2020 target (1.4), but at or below national average (3.0)*Above national average (>3.0)**Numbers of TB cases per 100,000 persons

In 2015, nine states and the District of Columbia reported incidences above the national average of 3.0 cases per 100,000. Incidences in 41 states were at or below the national average of 3.0 cases per 100,000.

Alaska, 9.6Hawaii, 9.3California, 5.5District of Columbia, 5.0Texas, 5.0New York, 3.9New Jersey, 3.7Georgia, 3.3Arkansas, 3.1Florida, 3.0Nevada, 3.0Maryland, 3.0Washington, 3.0Arizona, 3.0Rhode Island, 2.9Massachusetts, 2.9Minnesota, 2.8Illinois, 2.7Louisiana, 2.6Virginia, 2.6Mississippi, 2.5Alabama, 2.5Delaware, 2.4New Mexico, 2.3South Carolina, 2.2North Carolina, 2.0South Dakota, 2.0Tennessee, 2.0Connecticut, 2.0Oregon, 1.9Indiana, 1.8Nebraska, 1.8Oklahoma, 1.8Pennsylvania, 1.6Kentucky, 1.5Missouri, 1.5Colorado, 1.4Maine, 1.4Michigan, 1.3Kansas, 1.3Utah, 1.3Ohio, 1.2Iowa, 1.2North Dakota, 1.2Wisconsin, 1.2Vermont, 1.1New Hampshire, 1.0Montana, 0.9Wyoming, 0.7Idaho, 0.7West Virginia,0.5

National Average

2020 Target

*Numbers of TB cases per 100,000 persons. Data source: NTSS.


of 12

Figures 3 and 4. TB Incidence*, US-born Persons, United States, 2015

l

D.C.

Met 2020 target (≤0.4)*Above 2020 target (0.4), but at or below national average (1.2)*Above national average (>1.2)**Numbers of TB cases per 100,000 U.S.-born persons

Alaska, 8.6Hawaii, 3.9District of Columbia, 2.7Arkansas, 2.6Texas, 2.6Mississippi, 2.2Georgia, 2.0Alabama, 2.0

South Carolina, 1.7Louisiana, 1.8

Florida, 1.6South Dakota, 1.5California, 1.4New Mexico, 1.3North Carolina, 1.2Oklahoma, 1.2Tennessee, 1.2Nevada, 1.1Arizona, 1.0New York, 1.0Delaware, 0.9Illinois, 0.9New Jersey, 0.9Maryland, 0.8Kentucky, 0.8Indiana, 0.8Washington, 0.8Montana, 0.7Oregon, 0.7Pennsylvania, 0.7Missouri, 0.6Virginia, 0.6

Michigan, 0.5Vermont, 0.5Ohio, 0.5Nebraska, 0.5

Massachusetts, 0.4Minnesota, 0.4Rhode Island, 0.4Connecticut, 0.4West Virginia, 0.4Kansas, 0.4Wisconsin, 0.4Wyoming, 0.4

Utah, 0.3Colorado, 0.3Maine, 0.3

Iowa, 0.2New Hampshire, 0.2

North Dakota, 0.1Idaho, 0.1

National Average

2020 Target

*Numbers of TB cases per 100,000 U.S.-born persons. Data source: NTSS.

In 2015, a total of 11 states met the 2020 national target of 0.4 cases per 100,000 U.S.-born persons; 23 states were short of the 2020 target, but reported incidences less than the national average of 1.2 cases per 100,000 U.S.-born persons.

Note: To ensure better consistency with annual published TB incidences, U.S and foreign-born state incidences included in this report were calculated using the U.S. Census Bureau’s Current Population Survey. Therefore, U.S. and foreign-born state incidences presented in this report may differ from U.S. and foreign-born state incidences calculated using population data from other sources, such as the American Community Survey.


of 12

Figures 5 and 6. TB Incidence*, Foreign-born Persons, United States, 2015

l

D.C.

Met 2020 target (≤11.1)*Above 2020 target (11.1), but at or below national average (15.1)*Above national average (>15.1)*Numbers of TB cases per 100,000 foreign-born persons

,

Hawaii, 36.8

,

South Dakota, 34.5Maine, 33.8Missouri, 31.9North Dakota, 30.0Minnesota, 25.3Mississippi, 23.2Nebraska, 23.1

Louisiana, 19.5District of Columbia, 19.2Tennessee, 18.8Washington, 18.8Indiana, 18.7Rhode Island, 17.9Kentucky, 17.9Iowa, 17.7Delaware, 17.6California, 17.3Virginia, 16.9Pennsylvania, 16.6Maryland, 16.6Texas, 16.4New Hampshire, 14.9Ohio, 14.9Michigan, 14.8Massachusetts, 14.7Vermont, 14.7Illinois, 13.8New Jersey, 13.8New York, 13.6West Virginia, 13.5Georgia, 13.5Wyoming, 13.3Arkansas, 13.2Connecticut, 13.1Montana, 13.1Arizona, 13.0Kansas, 12.9Alabama, 12.8Alaska, 12.5Oregon, 11.6North Carolina, 11.3South Carolina, 10.9New Mexico, 10.7Nevada, 10.3Colorado, 10.2Oklahoma, 10.0Utah, 9.1Florida, 8.8Idaho, 8.7

Wisconsin, 20.3

National Average

2020 Target

In 2015, a total of 8 states met the 2020 national target of 11.1 cases per 100,000 foreign-born persons; 20 states were short of the 2020 target, but still reported incidences of less than the national average of 15.1 cases per 100,000 foreign-born persons.

*Numbers of TB cases per 100,000 foreign-born persons. Data source: NTSS.

Note: To ensure better consistency with annual published TB incidences, U.S and foreign-born state incidences included in this report were calculated using the U.S. Census Bureau’s Current Population Survey. Therefore, U.S. and foreign-born state incidences presented in this report may differ from U.S. and foreign-born state incidences calculated using population data from other sources, such as the American Community Survey.


of 12

Figures 7 and 8. TB Incidence*, US-born Non-Hispanic Blacks or African Americans, United States, 2015

l

D.C.

No reported TB cases among U.S.-bornnon-Hispanic black persons Met 2020 target (≤1.5)*Above 2020 target (1.5), but at or below national average (3.3)*Above national average (>3.3)**Numbers of TB cases per 100,000 U.S.-born non-Hispanic black persons

Texas, 6.7

Arkansas, 6.3Alabama, 4.9South Carolina, 4.7Florida, 4.6Mississippi, 4.5

Georgia, 4.2District of Columbia, 4.2

Nevada, 4.1Washington, 4.1Minnesota, 3.6

Tennessee, 3.2New York, 3.1Pennsylvania, 3.1

California, 3.1

Illinois, 2.7New Mexico, 2.6

Louisiana, 2.6

North Carolina, 2.3Connecticut, 2.2Indiana, 2.2Arizona, 2.1Wisconsin, 2.0

Michigan, 1.9Oklahoma, 1.9

Oregon, 1.8Virginia, 1.6Maryland, 1.6New Jersey, 1.6Ohio, 1.5

Massachusetts, 1.4Kentucky, 1.3Missouri, 1.2

Delaware, 1.1Iowa, 1.1Colorado, 0.6

National Average

2020 Target

*Numbers of TB cases per 100,000 U.S.-born non-Hispanic black persons. Data source: NTSS.

In 2015, a total of 6 states met the 2020 national target of 1.5 cases per 100,000 U.S.-born non-Hispanic black persons; 19 states were short of the 2020 target, but still reported incidences of less than the national average of 3.3 cases per 100,000 U.S.-born non-Hispanic black persons. Fifteen states did not report any cases of TB among U.S.-born non-Hispanic black persons.


of 12

For more information, see Reported Tuberculosis in the United States, 2015 at http://www.cdc.gov/tb/statistics/default.htm. If you need additional state-specific data not available in this report, you can contact your state TB control office at http://www.cdc.gov/tb/links/tboffices.htm.

Completion of Therapy Fully treating and, therefore, preventing further spread of Mycobacterium tuberculosis is key to TB control and elimination. If TB drugs are stopped too soon or not taken correctly, a person may become sick again or drug resistance may develop, enabling the further spread of TB. Each patient is unique, and there are many reasons why a patient might be unable or unwilling to complete TB treatment such as no longer experiencing symptoms of TB, not fully understanding the treatment regimen, not being willing or able to manage side effects of their treatment regimen, cultural beliefs, language barriers, difficulty getting health care, substance abuse, or mental health issues. Completion of therapy among persons who have experienced homelessness or been incarcerated can be particularly challenging due to difficulty locating patients for follow up care and treatment, and also particularly important because of the risk of transmission through shelter and jail or prison systems. There are several ways to increase treatment completion. These include directly observed therapy (in which patients are observed to ingest each dose of anti-TB medications) and use of incentives and enablers (e.g., giftcards for food or bus fare for transportation to get to and from the health department).

TB treatment is complex and can take several months to complete. It can take up to 2 years to have full treatment information reported for each TB patient. As a result, the most recent information available on completion of therapy is from 2013. For these patients, 12 states met or exceeded the 2020 national target of 95.0% of TB cases completing a full treatment regimen in 12 months or less; 16 states were short of the 2020 target, but exceeded the national average (89.6%) (Figure 9 on page 8). However, in 2013 there were 11 states that reported 9 or more TB patients, 15 years of age or older who were homeless; 6 of these states exceeded the national average of 85.2% completion of therapy among homeless TB patients (Table 1 on page 12). There were 8 states in 2013 that reported 5 or more TB patients, 15 years of age or older who were incarcerated; 4 of these states exceeded the national average of 79.8% completion of therapy among incarcerated TB patients (Table 2 on page 12).

HIV StatusPeople living with HIV are more likely than others to become sick with TB if they are exposed and infected. The risk of death from TB is also higher in HIV -infected persons. Untreated LBTI (see below) may quickly progress to TB disease in people living with HIV because the immune system is already weakened. Without treatment, TB disease can progress from sickness to death rapidly. Measuring the number of TB patients who are also tested for HIV and have a known HIV status is not only important in terms of saving lives, but also in interrupting the spread of TB and HIV to others.

In 2015, 24 states and the District of Columbia performed above the national average (88.5%) and 9 states met the 2020 national target of having HIV status known among at least 98.0% of reported TB cases (Figure 10 on page 9).

Treatment for LTBI When a person with infectious TB coughs, droplet nuclei containing M. tuberculosis are expelled into the air. If another person inhales air containing these droplet nuclei, he or she may become infected. However, not everyone infected with TB bacteria develops symptoms of TB. As a result, two TB-related conditions exist: LTBI and TB disease. Persons with LTBI do not feel sick and do not have any symptoms. They are infected with M. tuberculosis, but do not have TB disease. The only sign of LTBI is a positive reaction to a TB skin test or TB blood test. Persons with LTBI are not infectious and cannot spread TB infection to others. However, at some point in their lives, 5–10% of all people with normal immune systems who have LTBI will become sick with TB disease. As previously described, the chances of progression from LTBI to TB disease are higher for persons with weakened immune systems, such as those infected with HIV. LTBI can be treated to prevent progression to TB disease. Thus, it is important, in terms of accelerating the decline in TB incidence, to measure how many people with LTBI begin and complete treatment.

http://www.cdc.gov/tb/statistics/default.htm

http://www.cdc.gov/tb/links/tboffices.htm

of 12


TB programs work to identify persons who are at high risk for LTBI or at high risk for developing symptom of TB once infected so that they can be offered testing and treatment for LTBI. High-risk persons include known close contacts of someone with infectious TB disease, persons from regions of the world with high TB incidence, and those who work or reside in facilities or institutions with people who are also at high risk for TB. Risk factors for developing TB disease once infected include HIV infection, injection drug use, evidence of prior healed TB, diabetes, or low body weight. Infants and children under the age of five years are also at higher risk of getting sick with TB disease once infected.

In 2014, the most recent year for which data are available, 10 states met or exceeded the 2020 national target of initiating treatment for 91.0% of people diagnosed with LTBI found during contact investigations; 26 states and the District of Columbia were short of the 2020 target, but exceeded the national average (71.6%) (Figure 11 on page 10).

In 2014, 20 states and the District of Columbia met or exceeded the 2020 national target of treatment completion for 81.0% of people diagnosed with LTBI through contact investigation and initiated treatment; 12 states were short of the 2020 target, but met or exceeded the national average of 73.5% (Figure 12 on page 11).

For more information about TB disease and TB prevention and control activities in the United States, visit the National TB Controllers Association website at: http://www.tbcontrollers.org and the CDC TB website at: http://www.cdc.gov/tb.

http://www.tbcontrollers.org/

http://www.cdc.gov/tb/


of 12

Figure 9: Percentage of Newly Diagnosed TB Cases Completing Treatment ≤12 Months, United States, 2013

Wyoming, 0Delaware, 35.3 (6/17)Arkansas, 72.1 (44/61)Louisiana, 74.2 (89/120)Missouri, 75.0 (63/84)Montana, 75.0 (3/4)North Dakota, 75.0 (6/8)

New Hampshire, 83.3 (10/12)South Dakota, 83.3 (5/6)Ohio, 83.9 (99/118)South Carolina, 84.8 (78/92)Washington, 84.8 (151/178)District of Columbia, 85.2 (23/27)Connecticut, 85.7 (42/49)Arizona, 86.3 (113/131)Oregon, 86.9 (53/61)Iowa, 87.8 (36/41)Texas, 88.2 (839/951)California, 88.5 (1,556/1,758)Georgia, 88.6 (257/290)Idaho, 88.9 (8/9)Illinois, 89.5 (239/267)Hawaii, 90.2 (92/102)Mississippi, 90.5 (38/42)Wisconsin, 90.5 (38/42)

Maryland, 91.3 (136/149)Kentucky, 91.5 (43/47)Maine, 91.7 (11/12)Massachusetts, 92.0 (137/149)New Jersey, 92.1 (232/252)Alaska, 92.5 (62/67)Oklahoma, 93.1 (54/58)Florida, 93.6 (512/547)New York, 93.7 (671/716)New Mexico, 94.1 (32/34)Minnesota, 94.4 (118/125)Virginia, 94.6 (140/148)Colorado, 94.8 (55/58)Nebraska, 95.0 (19/20)Michigan, 95.3 (102/107)Rhode Island, 95.7 (22/23)Alabama, 95.7 (90/94)Indiana, 96.1 (74/77)Nevada, 96.2 (75/78)Tennessee, 96.6 (114/118)North Carolina, 97.8 (174/178)Kansas, 100.0 (30/30)Utah, 100.0 (28/28)Vermont, 100.0 (4/4)West Virginia, 100.0 (9/9)

Pennsylvania, 76.1 (134/176)

National Average:89.6%

2020 Target:95.0%

Note: DC, DE, IA, ID, KS, ME, MT, ND, NE, NH, NM, RI, SD, UT, VT, WI, WV, and WY reported 50 or fewer TB cases in 2013. Due to the small denominator, data should be interpreted with caution. The fraction in each parenthesis reports the number of TB patients who completed treatment within 12 months out of the total number of patients who were eligible to complete treatment within 12 months. Data source: NTSS.


of 12

Figure 10: Percentage of TB Cases with Known HIV Status (Positive or Negative), United States, 2015

Massachusetts, 51.1 (97/190)West Virginia, 75.0 (6/8)South Dakota, 76.5 (13/17)Wisconsin, 78.8 (52/66)Alaska, 82.1 (55/67)New Jersey, 82.3 (260/316)New York, 84.4 (635/752)Nebraska, 84.8 (28/33)Delaware, 85.7 (18/21)Pennsylvania, 85.8 (169/197)Louisiana, 86.3 (101/117)Missouri, 86.7 (78/90)Ohio, 87.1 (121/139)Indiana, 88.6 (101/114)Montana, 88.9 (8/9)California, 89.0 (1,860/2,091)Washington, 89.4 (178/199)Iowa, 89.5 (34/38)Illinois, 89.6 (301/336)Rhode Island, 89.7 (26/29)District of Columbia, 90.0 (27/30)Florida, 90.4 (527/583)Michigan, 90.8 (118/130)Idaho, 90.9 (10/11)Texas, 90.9 (1,192/1,311)Minnesota, 91.9 (136/148)Maryland, 92.0 (160/174)Oklahoma, 92.2 (59/64)South Carolina, 93.0 (93/100)Georgia, 93.7 (296/316)Arizona, 93.8 (181/193)Maine, 94.1 (16/17)Kansas, 94.3 (33/35)Connecticut, 95.7 (67/70)Colorado, 95.8 (69/72)Nevada, 96.3 (79/82)Hawaii, 96.8 (122/126)Mississippi, 97.2 (70/72)Alabama, 97.4 (114/117)New Mexico, 97.6 (41/42)North Carolina, 97.9 (189/193)Virginia, 98.1 (204/208)Tennessee, 98.4 (126/128)Kentucky, 98.5 (66/67)Oregon, 98.7 (74/75)Arkansas, 100.0 (87/87)North Dakota, 100.0 (9/9)New Hampshire, 100.0 (12/12)Utah, 100.0 (37/37)Vermont, 100.0 (7/7)

Wyoming, 0


2020 Target:98.0%

Note: DC, DE, IA, ID, KS, ME, MT, ND, NE, NH, NM, RI, SD, UT, VT, WI, WV, and WY reported 50 or fewer TB cases in 2013. Due to the small denominator, data should be interpreted with caution. The fraction in each parenthesis reports the number of TB patients with either positive or negative HIV test results out of the total number of TB patients. Data source: NTSS.


of 12

Figure 11: Percentage of Contacts (to Sputum Acid-Fast Bacilli Smear-Positive TB Patients) Newly Diagnosed with LBTI Who Began Treatment, United States, 2014

Alaska, 28.3 (17/60)North Dakota, 45.0 (9/20)Connecticut, 52.4 (11/21)

Virginia, 56.4 (141/250)Pennsylvania, 57.1 (92/161)California, 60.6 (1,213/2,003)Oklahoma, 60.9 (42/69)Ohio, 66.2 (43/65)Georgia, 67.1 (331/493)Texas, 68.3 (1,034/1,513)Hawaii, 70.0 (28/40)Massachusetts, 70.2 (87/124)Utah, 73.0 (46/63)Illinois, 73.7 (115/156)Louisiana, 74.3 (55/74)Rhode Island, 75.9 (44/58)

Maryland, 76.4 (68/89)North Carolina, 76.6 (271/354)New Mexico, 77.8 (21/27)Colorado, 78.9 (30/38)South Carolina, 79.1 (68/86)Florida, 79.6 (301/378)New York, 80.6 (498/618)Kentucky, 80.9 (34/42)Iowa, 83.3 (10/12)Washington, 83.3 (75/90)Arizona, 83.7 (108/129)Michigan, 84.3 (102/121)Oregon, 84.5 (60/71)Alabama, 85.2 (340/399)New Jersey, 85.9 (164/191)Maine, 85.9 (164/191)Indiana, 87.2 (95/109)New Hampshire, 87.5 (14/16)West Virginia, 87.5 (7/8)Wisconsin, 87.7 (57/65)Nevada, 87.9 (29/33)Arkansas, 90.2 (193/214)District of Columbia, 90.9 (10/11)Minnesota, 91.8 (67/73)Tennessee, 92.5 (161/174)Mississippi, 92.6 (112/121)Missouri, 94.3 (33/35)Nebraska, 95.0 (57/60)Delaware, 100.0 (9/9)Idaho, 100.0 (2/2)Kansas, 100.0 (25/25)Montana, 100.0 (1/1)South Dakota, 100.0 (28/28)


2020 Target:91.0%

Note: MT and WY reported zero contacts diagnosed with TB infection. Data should be interpreted with caution because of the small denominator. The fraction in each parenthesis reports the number of contacts who started treatment out of those contacts newly diagnosed with TB infection. Data source: Aggregate Reports for Program Evaluation.


of 12

Figure 12: Percentage of Contacts (to Sputum Acid-Fast Bacilli Smear-Positive TB Patients) Newly Diagnosed with LBTI Who Completed Treatment, United States, 2014

Nebraska, 17.5 (10/57)Arizona, 50.0 (54/108)Missouri, 51.5 (17/33)Massachusetts, 54.0 (47/87)Washington, 58.7 (44/75)Alaska, 64.7 (11/17)Maine, 65.0 (13/20)Louisiana, 65.5 (36/55)Florida, 65.8 (198/301)

Georgia, 67.1 (222/331)Texas, 67.1 (694/1,034)West Virginia, 71.4 (5/7)Rhode Island, 72.7 (32/44)Pennsylvania, 72.8 (67/92)California, 73.2 (888/1,213)Kentucky, 73.5 (25/34)Ohio, 73.5 (4,522/6,156)Oklahoma, 74.4 (32/43)Illinois, 76.2 (32/42)New York, 76.5 (88/115)Wisconsin, 76.7 (382/498)Michigan, 77.2 (44/57)Minnesota, 77.5 (79/102)Hawaii, 77.6 (52/67)North Carolina, 78.6 (22/28)Indiana, 78.6 (213/271)Iowa, 80.0 (76/95)Utah, 80.0 (8/10)Nevada, 80.4 (37/46)Tennessee, 82.8 (24/29)

Oregon, 83.2 (134/161)New Jersey, 83.3 (50/60)Arkansas, 85.4 (140/164)Virginia, 85.5 (165/193)Delaware, 87.9 (124/141)South Dakota, 88.9 (8/9)South Carolina, 89.3 (25/28)Colorado, 89.7 (61/68)District of Columbia, 90.0 (27/30)Mississippi, 90.0 (9/10)Connecticut, 90.2 (101/112)Maryland, 90.9 (10/11)Kansas, 91.2 (62/68)Alabama, 92.0 (23/25)New Hampshire, 92.6 (315/340)New Mexico, 92.9 (13/14)Idaho, 95.2 (20/21)Montana, 100.0 (2/2)North Dakota, 100.0 (1/1)


2020 Target:81.0%

Note: MT and WY reported zero contacts diagnosed with TB infection. Data should be interpreted with caution because of the small denominator. The fraction in each parenthesis reports the number of contacts newly diagnosed with TB infection who completed treatment out of those contacts who started treatment. Data source: Aggregate Reports for Program Evaluation..


of 12

Table 1. Treatment Completion within ≤12 Months among Newly Diagnosed TB Patients Age ≥15 Who were Homeless within the Year Prior to Diagnosis, United States, 2013

Statesa with 1 to 3 TB

patients age ≥15 who were homeless

Percentage of homeless

patients age ≥15 who completed treatment within

12 monthsb

Percentage of all patients

who completed treatment within

12 monthsc

Statesa with4 to 8 TB

patients age ≥15 who were

homeless



12 monthsb



12 monthsc

Statesa with9 or more TB patients age ≥15 who were

homeless



12 monthsb



12 monthsc

Dist. of Columbia 100 85 Alaska 100 93 Indiana 100 96Kansas 100 100 Alabama 100 96 North Carolina 100 98Kentucky 100 91 Colorado 100 95 Florida 98 94Massachusetts 100 92 Michigan 100 95 Georgia 92 89Maryland 100 91 Tennessee 100 97 Arizona 89 86Minnesota 100 94 Virginia 100 95 New York 87 94Mississippi 100 90 Hawaii 80 90 Texas 83 88North Dakota 100 75 Louisiana 75 74 California 81 89New Hampshire 100 83 Pennsylvania 75 76 New Jersey 78 92New Mexico 100 94 South Carolina 75 85 Illinois 73 90Nevada 100 96 Washington 75 85 Arkansas 50 72Oregon 100 87 Ohio 60 84Utah 100 100Wisconsin 100 90Connecticut 67 86Iowa 67 88Oklahoma 33 93Maine 0 92Missouri 0 75

aCategorized based on lower third, middle third, and upper third numbers of cases reported among homeless persons age ≥15 who were eligible to complete treatment within 12 months; bAmong those age ≥15 who were eligible to complete treatment within 12 months; and Among all patients of any age who were eligible to complete treatment within 12 months. Note: DE, ID, MT, NE, RI, SD, VT, WV, WY did not report TB cases among persons age ≥15 experiencing homelessness who were eligible to complete treatment.

Table 2. Treatment Completion within ≥12 Months among Newly Diagnosed TB Patients Age ≥15 Who were Incarcerated at the Time of Diagnosis, United States, 2013

Statesa with< 2 TB

patients age ≥15 who were incarcerated

Percentage of incarcerated


12 monthsb



12 monthsc

Statesa with2 to 4 TB

patients age ≥15 who were incarcerated



12 monthsb


who completed treatment within 12

monthsc

Statesa with5 or more TB patients age ≥15 who were incarcerated



12 monthsb



12 monthsc

Alaska 100 93 Illinois 100 90 New York 100 94Colorado 100 95 Kentucky 100 91 Tennessee 100 97Hawaii 100 90 Michigan 100 95 Arizona 85 86Iowa 100 88 Oklahoma 100 93 North Carolina 80 98Kansas 100 100 Oregon 100 87 California 79 89New Hampshire 100 83 Arkansas 100 72 Texas 78 88New Jersey 100 92 Mississippi 100 90 Florida 76 94Nevada 100 96 Louisiana 75 74 Georgia 70 89Wisconsin 100 90 South Carolina 75 85Massachusetts 0 92 Pennsylvania 50 76

Washington 33 85Missouri 0 75

aCategorized based on lower third, middle third, and upper third numbers of cases reported among incarcerated persons age ≥15 who were eligible to complete treatment within 12 months; bAmong those age ≥15 who were eligible to complete treatment within 12 months; and cAmong all patients of any age who were eligible to complete treatment within 12 months. Note: AL, CT, DC, DE, ID, IN, MD, ME, MN, MT, ND, NE, NM, OH, RI, SD, UT, VA, VT, WV, WY did not report TB cases among incarcerated persons age ≥15 who were eligible to complete treatment.

NATIONAL TUBERCULOSIS INDICATORS · CDC publishes TB indicator data to assist in evaluating...

Documents

Transcript of NATIONAL TUBERCULOSIS INDICATORS · CDC publishes TB indicator data to assist in evaluating...